When Donald Trump unveiled his “One Big Beautiful Bill” last month, all the focus was on how the president’s trillions of tax ...

From drug trials to mechanistic insights, EULAR 2025 delivers wide-ranging data that may inform tomorrow’s standards in ...

Targeted therapies and immunotherapy can provide benefits when added to chemotherapy or may eliminate the need for ...

As practicing oncologists, we can get bogged down in our individual practices and thus have trouble seeing the bigger picture ...

AI has been a buzzword in the pharmaceutical industry for almost a decade, with countless headlines promising to ...

There is a long and ignominious tradition of idiotic comments by ministers thrust into the political centre-stage with no ...

Robert F. Kennedy Jr. had fired all 17 members of a key vaccine panel. Now his new panel recommended a new infant RSV vaccine ...

Robert F. Kennedy Jr. had fired all 17 members of a key vaccine panel. Now his new panel recommended a new infant RSV vaccine ...

The votes in favor of Merck’s shot are a sigh of relief after Kennedy gutted the panel and tapped replacements, some of whom ...

The growing incidence of infectious diseases, cancer, and chronic illnesses has substantially increased the demand for ...

MCP is rapidly gaining momentum as a standardised, open-source framework for enabling secure bidirectional communication ...

GiveCard, a platform purpose-built to help nonprofits and government agencies disburse and manage funds over prepaid funds, today announced a strategic collaboration with Visa. GiveCard will be ...